1. Home
  2. HAE vs LGN Comparison

HAE vs LGN Comparison

Compare HAE & LGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HAE

Haemonetics Corporation

HOLD

Current Price

$119.47

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Logo Legence Corp.

LGN

Legence Corp.

N/A

Current Price

$51.55

Market Cap

4.1B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HAE
LGN
Founded
1971
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.1B
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
HAE
LGN
Price
$119.47
$51.55
Analyst Decision
Buy
Strong Buy
Analyst Count
11
17
Target Price
★ $111.50
$102.53
AVG Volume (30 Days)
472.9K
★ 806.5K
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.72
N/A
Revenue
$910,373,000.00
★ $2,550,491,000.00
Revenue This Year
$6.21
$87.60
Revenue Next Year
$5.54
$13.82
P/E Ratio
$141.61
★ N/A
Revenue Growth
N/A
★ 21.53
52 Week Low
$48.17
$30.65
52 Week High
$110.45
$107.24

Technical Indicators

Market Signals
Indicator
HAE
LGN
Relative Strength Index (RSI) 75.86 40.43
Support Level $72.93 $48.60
Resistance Level N/A $53.65
Average True Range (ATR) 2.90 2.46
MACD 0.07 0.26
Stochastic Oscillator 91.67 17.55

Price Performance

Historical Comparison
HAE
LGN

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

About LGN Legence Corp.

Legence Corp is a provider of engineering, installation, and maintenance services for critical systems in buildings. It focuses on sectors that have technically demanding buildings, including technology, life sciences, healthcare, and education. Legence specializes in designing, fabricating, and installing complex heating, ventilation, and air conditioning (HVAC), process piping, and other mechanical, electrical, and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting, and building controls in existing facilities to enhance building performance, reliability, and efficiency. The services are mainly provided on a fixed price basis. The company has two reportable segments: Installation and Maintenance, which generates the maximum revenue, and Engineering and Consulting.

Share on Social Networks: